20th March 2020
Takis Biotech is looking for support during COVID-19 vaccine development
Takis Biotech is developing a COVID-19 vaccine based on DNA delivered by electroporation (EP). The technology is simple, fast and solid and can be applied all over Europe thanks to the use of a delivery apparatus (Cliniporator TM) already present in 140 European Institutes.
Takis is keen to hear from anyone who may be able to support their clinical trials and is open to all types of support.
ASK: Research contributors needed for CON-VICE study
University of Luxembourg needs European researchers to get in touch
OFFER: Funding available for COVID-19 research
Fondation Air Liquide are looking to fund European projects
ASK: Supporting the immunocompromised
Partners sought to advance neutralising antibody